Skip to main content
Premium Trial:

Request an Annual Quote

Beckman's Acquisition of Olympus Dx Business Clears FTC

NEW YORK (GenomeWeb News) – Beckman Coulter today said that its pending $780 million acquisition of the diagnostics business of Olympus has cleared US antitrust review by the Federal Trade Commission.

The firm said that it expects to close the deal in the third quarter of 2009, subject to certain additional conditions including approval from governments outside of the US.

Beckman announced the deal, which will provide it with an expanded clinical chemistry offering with particular strength in the larger hospital laboratories, at the end of February.

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.